Venter H - Search Results

1

Synthesis and Biological Evaluation of Novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as Potential Antimicrobial Agents.

Qiang S, Wang C, Venter H, Li X, Wang Y, Guo L, Ma R, Ma S. Qiang S, et al. Among authors: venter h. Chem Biol Drug Des. 2016 Feb;87(2):257-64. doi: 10.1111/cbdd.12658. Epub 2015 Sep 28. Chem Biol Drug Des. 2016. PMID: 26348110

2

RND-type drug eﬄux pumps from Gram-negative bacteria: molecular mechanism and inhibition.

Venter H, Mowla R, Ohene-Agyei T, Ma S. Venter H, et al. Front Microbiol. 2015 Apr 28;6:377. doi: 10.3389/fmicb.2015.00377. eCollection 2015. Front Microbiol. 2015. PMID: 25972857 Free PMC article. Review.

3

Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.

Wang Y, Venter H, Ma S. Wang Y, et al. Among authors: venter h. Curr Drug Targets. 2016;17(6):702-19. doi: 10.2174/1389450116666151001103948. Curr Drug Targets. 2016. PMID: 26424403 Review.

4

Synthesis and antibacterial activity of novel 3-O-descladinosylazithromycin derivatives.

Yan M, Ma R, Jia L, Venter H, Ma S. Yan M, et al. Among authors: venter h. Eur J Med Chem. 2017 Feb 15;127:874-884. doi: 10.1016/j.ejmech.2016.10.065. Epub 2016 Nov 1. Eur J Med Chem. 2017. PMID: 27836198

5

Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition.

Bi F, Guo L, Wang Y, Venter H, Semple SJ, Liu F, Ma S. Bi F, et al. Among authors: venter h. Bioorg Med Chem Lett. 2017 Feb 15;27(4):958-962. doi: 10.1016/j.bmcl.2016.12.081. Epub 2017 Jan 3. Bioorg Med Chem Lett. 2017. PMID: 28082038

6

Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.

Wang Y, Mowla R, Guo L, Ogunniyi AD, Rahman T, De Barros Lopes MA, Ma S, Venter H. Wang Y, et al. Among authors: venter h. Bioorg Med Chem Lett. 2017 Feb 15;27(4):733-739. doi: 10.1016/j.bmcl.2017.01.042. Epub 2017 Jan 16. Bioorg Med Chem Lett. 2017. PMID: 28129976

7

Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors.

Liu F, Venter H, Bi F, Semple SJ, Liu J, Jin C, Ma S. Liu F, et al. Among authors: venter h. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3399-3402. doi: 10.1016/j.bmcl.2017.06.005. Epub 2017 Jun 3. Bioorg Med Chem Lett. 2017. PMID: 28633894

8

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.

Ogunniyi AD, Khazandi M, Stevens AJ, Sims SK, Page SW, Garg S, Venter H, Powell A, White K, Petrovski KR, Laven-Law G, Tótoli EG, Salgado HR, Pi H, Coombs GW, Shinabarger DL, Turnidge JD, Paton JC, McCluskey A, Trott DJ. Ogunniyi AD, et al. Among authors: venter h. PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017. PLoS One. 2017. PMID: 28873428 Free PMC article.

9

Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.

Mowla R, Wang Y, Ma S, Venter H. Mowla R, et al. Among authors: venter h. Biochim Biophys Acta Biomembr. 2018 Apr;1860(4):878-886. doi: 10.1016/j.bbamem.2017.08.024. Epub 2017 Sep 8. Biochim Biophys Acta Biomembr. 2018. PMID: 28890187 Free article.

10

Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors.

Wang Y, Mowla R, Ji S, Guo L, De Barros Lopes MA, Jin C, Song D, Ma S, Venter H. Wang Y, et al. Among authors: venter h. Eur J Med Chem. 2018 Jan 1;143:699-709. doi: 10.1016/j.ejmech.2017.11.102. Epub 2017 Dec 5. Eur J Med Chem. 2018. PMID: 29220791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters